Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • Recipients Of J&J COVID-19 Vaccine May Benefit More From Moderna Or Pfizer Booster, Study Suggests

    USA Today (10/13, Weise) reports, “The best booster for the Johnson & Johnson COVID-19 vaccine may be either Pfizer-BioNTech or Moderna, according to” a National Institutes of Health preprint study (PDF) released Wednesday. Researchers in the 500-particip...
    Full Article
  • Plasma D-Dimer Assay Unreliable For Ruling Out PE In Hospitalized Patients With COVID-19, Study Suggests

    Medscape (10/13, Lowry, Subscription Publication) reports, “The plasma D-dimer assay has been used, along with clinical prediction scores, to rule out pulmonary embolism (PE) in critically ill patients for decades,” but a new study published in JAMA Netwo...
    Full Article
  • Animal Cell Culture-Developed Flu Vaccine Effective In Children, Trial Finds

    MedPage Today (10/13, Phend) reports, “Flu vaccine generated with a novel platform, using animal cell culture rather than egg, appeared to have good protection for children,” researchers concluded in a clinical trial including 4,514 children. Results show...
    Full Article
  • Virologic Suppression Maintained During Treatment With B/F/TAF In African American Adults With HIV, Findings Show

    Infectious Disease Advisor (10/13, van Paridon) reports, “Among African American patients with HIV infection, virologic suppression was maintained during treatment with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF), regardless of pre-existing...
    Full Article
  • COVID-19 Cases Dropping Overall In North America, PAHO Says

    Reuters (10/13, Boadle) reports, “The Pan American Health Organization (PAHO) said on Wednesday that COVID-19 cases are dropping overall in North America but remain high in the American Midwest, Alaska, and Canada’s Northwest Territories, where infection...
    Full Article
  • Some Caribbean Countries Struggling With COVID-19 Vaccination Efforts

    The New York Times (10/13, Politi) reports that “across the Caribbean, countries are grappling with unequal distribution of doses and vaccine hesitancy, World Health Organization officials warned” on Wednesday. In the Americas, four of the six countries “...
    Full Article
  • FDA Review Suggests Booster Doses For J&J’s COVID-19 Vaccine Recipients Beneficial, Despite Limited Data

    The Wall Street Journal (10/13, Loftus, Schwartz, Subscription Publication) reports the FDA on Wednesday said limited evidence suggests a booster shot of Johnson & Johnson’s COVID-19 vaccine significantly bolsters the immune defenses of study participants...
    Full Article
  • WHO Begins Ebola Vaccinations In Congo After Death Of Toddler Last Week

    The AP (10/13, Cheng) reports that the World Health Organization “said Wednesday that officials have begun vaccinating people in eastern Congo against Ebola, after it was confirmed last week that the disease killed a toddler.” The UN health agency “said i...
    Full Article
  • WHO Names 26 Scientists To Investigate Origins Of SARS-CoV-2 And Other Outbreaks

    The Washington Post (10/13, Taylor) reports, “The World Health Organization on Wednesday named 26 scientists to a new advisory body devoted to understanding the origins of the coronavirus and other future outbreaks, marking a significant change in approac...
    Full Article
  • FDA Remains Neutral On Need For Moderna COVID-19 Booster

    The New York Times (10/12, LaFraniere) reports, “The Food and Drug Administration set the stage Tuesday for a new round of decisions on which Americans should get coronavirus booster shots, releasing a review of data suggesting that an additional half-dos...
    Full Article
  • People With Natural Immunity Should Still Get Vaccinated Against SARS-CoV-2, Some Experts Say

    The New York Times (10/12, Mandavilli) reports while “those with powerful natural immunity may be protected from reinfection for up to a year,” it is still inadvisable to “skip the vaccine, experts said.” One reason is that “boosting their immunity with a...
    Full Article
  • Past Pandemics Suggest COVID-19 Will Have Lasting Impact, Some Experts Say

    The New York Times’ (10/12) Gina Kolata writes that while many “wonder when the pandemic will end,” Harvard University historian of science and medicine Allan Brandt said, “We tend to think of pandemics and epidemics as episodic. But we are living in the...
    Full Article
  • Virus Evolution A Long Game, And Relationship With SARS-CoV-2 Is Still Young, Scientists Say

    The New York Times (10/12, Anthes) reports, “Even for a virus, evolution is a long game, and our relationship with SARS-CoV-2 is still in its infancy,” scientists say. The population is “extremely unlikely to eradicate the virus, scientists say, and what...
    Full Article
  • More COVID-19 Vaccinations Could Have Saved 22K Lives In Texas And Florida, Collectively, Study Finds

    Bloomberg (10/12, Saraiva) reports a study published in The Lancet found that “if 74% of Texans and Floridians had been vaccinated by the end of August, they could have collectively had 95,000 fewer hospitalizations and 22,000 fewer deaths.” Bloomberg add...
    Full Article
  • Risk Of Contracting SARS-CoV-2 From Grocery Store Surfaces Minimal, Researchers Say

    HealthDay (10/12, Murez) reports researchers who “collected 957 samples at four grocery stories over a month” and conducted PCR testing of the samples found no trace of SARS-CoV-2, suggesting the chances of contracting “COVID-19 from surfaces at the groce...
    Full Article
  • CureVac Dropping One COVID-19 Vaccine, Shifts Focus To Second GSK-Partnered Candidate

    Reuters (10/12, Szymanska, Burger) reports CureVac “said on Tuesday it will give up on its first-generation COVID-19 vaccine candidate and instead focus on collaborating with GSK to develop improved mRNA vaccine technology.” The company will “abandon its...
    Full Article
  • US To Reopen Land Borders In November For Inoculated Visitors

    The AP (10/13, Miller) reports the US “will reopen its land borders to nonessential travel next month, ending a 19-month freeze due to the COVID-19 pandemic as the country moves to require all international visitors to be vaccinated against the coronaviru...
    Full Article
  • FDA Scientists Say Moderna Has Not Met Criteria To Support Use Of COVID-19 Boosters

    Reuters (10/12, Erman, Steenhuysen) reports FDA researches on Tuesday “said on Tuesday that Moderna Inc had not met all of the agency’s criteria to support use of booster doses of its COVID-19 vaccine, possibly because the efficacy of the shot’s first two...
    Full Article
  • White House Tells Governors To Prepare To Distribute COVID-19 Vaccines For Younger Children

    ABC News (10/12, Flaherty, Faulders) reports, “In a private phone call Tuesday with the nation’s governors, the White House said states should prepare to begin vaccinating elementary-school-aged kids against COVID-19 in early November and that it would wo...
    Full Article
  • Drug Developer Applies For FDA Emergency Authorization For Anti-COVID Pill Molnupiravir

    The New York Times (10/11, Robbins) reports Merck & Co. has submitted an application to the FDA “to authorize what would be the first antiviral pill to treat COVID-19” and “a milestone in the fight against the coronavirus.” The therapy, “taken at home as...
    Full Article
  • «
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id